Lakeland Clinical Trials is conducting a clinical trial to evaluate the safety and efficacy of different formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Cell-derived Influenza Vaccine (aQIVc) in Older Adults ≥50 Years of Age
You may be eligible to participate if:
- You are aged over 50
- Have not received a flu vaccination in the last 6 months
This trial is no longer enrolling but if you would like to register your interest for future clinical trials please apply via the 'APPLY TO PARTICIPATE' button.